Key statistics
On Thursday, Lineage Cell Therapeutics Inc (LCTX:TLV) closed at 340.50, 12.27% above the 52 week low of 303.30 set on Aug 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 344.10 |
---|---|
High | 344.10 |
Low | 334.40 |
Bid | 335.30 |
Offer | 340.50 |
Previous close | 339.00 |
Average volume | 6.45k |
---|---|
Shares outstanding | 188.84m |
Free float | 188.00m |
P/E (TTM) | -- |
Market cap | 177.51m USD |
EPS (TTM) | -0.1342 USD |
Data delayed at least 20 minutes, as of Sep 19 2024 15:24 BST.
More ▼
Press releases
- Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
- Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
- Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index
More ▼